PORT-77

N/A

Report date: 2025/05/26 15:34:02
NME

Base Information

Drug NamePORT-77
Drug Alias NamePORT-77
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors
TargetsBroad substrate specificity ATP-binding cassette transporter ABCG2
Therapy Area/IndicationsProtoporphyria, Erythropoietic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPortal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPortal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProtoporphyria, Erythropoietic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A